Long-term oncologic outcomes of laparoscopic versus open surgery for rectal cancer: A pooled analysis of 3 randomized controlled trials

Annals of Surgery

Volumn 259, Issue 1, 2014, Pages 139-147

  Ng, Simon S M ^a   Lee, Janet F Y ^a   Yiu, Raymond Y C ^a   Li, Jimmy C M ^a   Hon, Sophie S F ^a   Mak, Tony W C ^a   Leung, Wing Wa ^a   Leung, Ka Lau ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Laparoscopic surgery; Oncologic outcomes; Pooled analysis; Randomized controlled trials; Rectal cancer

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEST INFECTION; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; DEMOGRAPHY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LONG TERM SURVIVAL; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONCOLOGICAL PARAMETERS; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECURRENCE RISK; REOPERATION; SURGICAL APPROACH; SURGICAL MORTALITY;

AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LAPAROSCOPY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84891626078     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31828fe119     Document Type: Article

References (33)

1. Guillou PJ, Quirke P, Thorpe H, et al. Short-Term endpoints of conventional versus laparoscopic-Assisted surgery in patients with colorectal cancer (MRC CLASICC trial): Multicentre, randomised controlled trial. Lancet. 2005;365:1718-1726.
2. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Short-Termoutcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637-645.
3. Zhou ZG, Hu M, Li Y, et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc. 2004;18:1211-1215.
4. Braga M, Frasson M, Vignali A, et al. Laparoscopic resection in rectal cancer patients: Outcome and cost-benefit analysis. Dis Colon Rectum. 2007;50:464-471.
5. Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg. 2009;96:982-989.
6. Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97:1638-1645.
7. Trastulli S, Cirocchi R, Listorti C, et al. Laparoscopic versus open resection for rectal cancer: A meta-Analysis of randomized clinical trials. Colorectal Dis. 2012;14:e277-e296.
8. Ohtani H, Tamamori Y, Azuma T, et al. A meta-Analysis of short- and long-Term results of randomized controlled trials that compared laparoscopyassisted and conventional open surgery for rectal cancer. J Gastrointest Surg. 2011;15:1375-1385.
9. HuangMJ, Liang JL,Wang H, et al. Laparoscopic-Assisted versus open surgery for rectal cancer: A meta-Analysis of randomized controlled trials on oncologic adequacy of resection and long-Term oncologic outcomes. Int J Colorectal Dis. 2011;26:415-421.
10. Clarke MJ, Stewart LA. Obtaining data from randomised controlled trials: How much do we need for reliable and informative meta-Analyses? BMJ. 1994;309:1007-1010.
11. Michiels S, Piedbois P, Burdett S, et al. Meta-Analysis when only the median survival times are known: A comparison with individual patient data results. Int J Technol Assess Health Care. 2005;21:119-125.
12. Ng SS, Leung KL, Lee JF, et al. MRC CLASICC trial. Lancet. 2005;366:713-714.
13. Ng SS, Leung KL, Lee JF, et al. Long-Term morbidity and oncologic outcomes of laparoscopic-Assisted anterior resection for upper rectal cancer: 10-year results of a prospective randomized trial. Dis Colon Rectum. 2009;52:558-566.
14. Ng SS, Leung KL, Lee JF, et al. Laparoscopic-Assisted versus open abdominoperineal resection for low rectal cancer: A prospective randomized trial. Ann Surg Oncol. 2008; 15:2418-2425.
15. Ng SS, Lee JF, Yiu RY, et al. Laparoscopic-Assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: A prospective randomized trial. Colorectal Dis. 2009;11(suppl 2):2.
16. Leung KL, Kwok SP, Lam SC, et al. Laparoscopic resection of rectosigmoid carcinoma: Prospective randomised trial. Lancet. 2004;363:1187-1192.
17. Tjandra JJ, Reading DM, McLachlan SA, et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: Preliminary results. Dis Colon Rectum. 2001;44:1113-1122.
18. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: The German trial CAO/ARO/AIO-94. Colorectal Dis. 2003;5:406-415.
19. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
20. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.
21. Morino M, Allaix ME, Giraudo G, et al. Laparoscopic versus open surgery for extraperitoneal rectal cancer: A prospective comparative study. Surg Endosc. 2005;19:1460-1467.
22. Laurent C, Leblanc F, Wütrich P, et al. Laparoscopic versus open surgery for rectal cancer: Long-Term oncologic results. Ann Surg. 2009;250:54-61.
23. Lacy AM,Garćia-Valdecasas JC,Delgado S, et al. Laparoscopy-Assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet. 2002;359:2224-2229.
24. Lacy AM, Delgado S, Castells A, et al. The long-Term results of a randomized clinical trial of laparoscopy-Assisted versus open surgery for colon cancer. Ann Surg. 2008;248:1-7.
25. Leung KL, Tsang KS, Ng MH, et al. Lymphocyte subsets and natural killer cell cytotoxicity after laparoscopically assisted resection of rectosigmoid carcinoma. Surg Endosc. 2003;17:1305-1310.
26. Leung KL, Lai PB,HoRL, et al. Systemic cytokine response after laparoscopicassisted resection of rectosigmoid carcinoma: A prospective randomized trial. Ann Surg. 2000;231:506-511.
27. Rothwell PM . Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation. Lancet. 2005;365:176-186.
28. Brookes ST,Whitely E, EggerM, et al. Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229-236.
29. Capussotti L, Massucco P, Muratore A, et al. Laparoscopy as a prognostic factor in curative resection of node positive colorectal cancer: Results for a singleinstitution nonrandomized prospective trial. Surg Endosc. 2004;18:1130-1135.
30. Law WL, Poon JT, Fan JK, et al. Survival following laparoscopic versus open resection for colorectal cancer. Int J Colorectal Dis. 2012;27:1077-1085.
31. Lim SB, Yu CS, Jang SJ, et al. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum. 2010;53: 377-384.
32. Amato A, Pescatori M . Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1:CD005033.
33. Edna TH, Bjerkeset T . Perioperative blood transfusions reduce long-Term survival following surgery for colorectal cancer. Dis Colon Rectum. 1998;41: 451-459.